SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Hollow Brook Wealth Management LLC

Hollow Brook Wealth Management LLC raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 4.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,669 shares of the exchange traded fund’s stock after acquiring an additional 1,003 shares during the quarter. Hollow Brook Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $2,141,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the company. Tidemark LLC grew its stake in shares of SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after acquiring an additional 199 shares in the last quarter. ORG Partners LLC purchased a new stake in SPDR S&P Biotech ETF during the 2nd quarter worth approximately $40,000. Quintet Private Bank Europe S.A. acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $40,000. ORG Wealth Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth approximately $44,000. Finally, Howe & Rusling Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth $49,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $99.79 on Monday. The company’s 50-day simple moving average is $98.22 and its 200-day simple moving average is $96.61. The stock has a market capitalization of $7.61 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $77.21 and a one year high of $105.47.

SPDR S&P Biotech ETF Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.